Genomic Activation of the EGFR and HER2-neu Genes in a Significant Proportion of Invasive Epithelial Ovarian Cancers

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-8-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

HER2/neu Overexpression in the Development of Muscle-Invasive Transitional Cell Carcinoma of the Bladder

British Journal of Cancer
Cancer ResearchOncology
2003English

Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2

Cancer Cell
Cancer ResearchOncologyCell Biology
2016English

Activating Mutations in HER2 : Neu Opportunities and Neu Challenges

Cancer Discovery
Oncology
2013English

The Prognostic Value of Morphometry in Advanced Epithelial Ovarian Cancers

British Journal of Cancer
Cancer ResearchOncology
1995English

Mammary Stromal Effects on Epithelial Differentiation and Expression of ESX and ErbB2 (HER2/neu)

2002English

Clinical Significance of HER2 and EGFR Expression in Colorectal Cancer Patients With Ovarian Metastasis

BMC Clinical Pathology
Forensic MedicinePathologyHistology
2019English

Functional Implications of Structural Predictions for Alternative Splice Proteins Expressed in Her2/Neu–Induced Breast Cancers

Journal of Proteome Research
BiochemistryChemistry
2011English

HER2 (EGFR2; ErbB2; Neu)

Science-Business eXchange
2013English

Expression Levels of HER2/neu and Those of Collocated Genes at 17q12-21, in Breast Cancer

Oncology Reports
MedicineCancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy